Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women

Andrea Ries Thurman, Neelima Chandra, Nazita Yousefieh, Irina Zalenskaya, Thomas Kimble, Susana Asin, Christiane Rollenhagen, Sharon M. Anderson, Betsy Herold, Pedro M M Mesquita, Nicola Richardson-Harman, Tina Cunningham, Jill L. Schwartz, Gustavo F. Doncel

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, antimicrobial activity of the cervicovaginal (CV) lavage (CVL), vaginal flora, and p24 antigen production from CV tissues after ex vivo human immunodeficiency virus (HIV) infection between follicular (FOL) and luteal (LUT) phases of the menstrual cycle. CV tissue biopsies, CV secretions, and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV-seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 and Escherichia coli by the CVL, vaginal pH or Nugent score, or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL phase versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials.

Original languageEnglish (US)
Pages (from-to)547-560
Number of pages14
JournalAIDS Research and Human Retroviruses
Volume32
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Follicular Phase
Luteal Phase
HIV
Vaginal Douching
Clinical Trials
Progesterone
Estradiol
Reproductive Tract Infections
Antigens
compound A 12
Human Herpesvirus 2
Corpus Luteum
Vagina
Virus Diseases
Menstrual Cycle
Contraceptive Agents
Infection
Serum
Transcriptome
Population

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Thurman, A. R., Chandra, N., Yousefieh, N., Zalenskaya, I., Kimble, T., Asin, S., ... Doncel, G. F. (2016). Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women. AIDS Research and Human Retroviruses, 32(6), 547-560. https://doi.org/10.1089/aid.2015.0264

Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women. / Thurman, Andrea Ries; Chandra, Neelima; Yousefieh, Nazita; Zalenskaya, Irina; Kimble, Thomas; Asin, Susana; Rollenhagen, Christiane; Anderson, Sharon M.; Herold, Betsy; Mesquita, Pedro M M; Richardson-Harman, Nicola; Cunningham, Tina; Schwartz, Jill L.; Doncel, Gustavo F.

In: AIDS Research and Human Retroviruses, Vol. 32, No. 6, 01.06.2016, p. 547-560.

Research output: Contribution to journalArticle

Thurman, AR, Chandra, N, Yousefieh, N, Zalenskaya, I, Kimble, T, Asin, S, Rollenhagen, C, Anderson, SM, Herold, B, Mesquita, PMM, Richardson-Harman, N, Cunningham, T, Schwartz, JL & Doncel, GF 2016, 'Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women', AIDS Research and Human Retroviruses, vol. 32, no. 6, pp. 547-560. https://doi.org/10.1089/aid.2015.0264
Thurman, Andrea Ries ; Chandra, Neelima ; Yousefieh, Nazita ; Zalenskaya, Irina ; Kimble, Thomas ; Asin, Susana ; Rollenhagen, Christiane ; Anderson, Sharon M. ; Herold, Betsy ; Mesquita, Pedro M M ; Richardson-Harman, Nicola ; Cunningham, Tina ; Schwartz, Jill L. ; Doncel, Gustavo F. / Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women. In: AIDS Research and Human Retroviruses. 2016 ; Vol. 32, No. 6. pp. 547-560.
@article{42a65fee9f7c4488bad0cc2d0a8a51ae,
title = "Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women",
abstract = "The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, antimicrobial activity of the cervicovaginal (CV) lavage (CVL), vaginal flora, and p24 antigen production from CV tissues after ex vivo human immunodeficiency virus (HIV) infection between follicular (FOL) and luteal (LUT) phases of the menstrual cycle. CV tissue biopsies, CV secretions, and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV-seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 and Escherichia coli by the CVL, vaginal pH or Nugent score, or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL phase versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials.",
author = "Thurman, {Andrea Ries} and Neelima Chandra and Nazita Yousefieh and Irina Zalenskaya and Thomas Kimble and Susana Asin and Christiane Rollenhagen and Anderson, {Sharon M.} and Betsy Herold and Mesquita, {Pedro M M} and Nicola Richardson-Harman and Tina Cunningham and Schwartz, {Jill L.} and Doncel, {Gustavo F.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1089/aid.2015.0264",
language = "English (US)",
volume = "32",
pages = "547--560",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women

AU - Thurman, Andrea Ries

AU - Chandra, Neelima

AU - Yousefieh, Nazita

AU - Zalenskaya, Irina

AU - Kimble, Thomas

AU - Asin, Susana

AU - Rollenhagen, Christiane

AU - Anderson, Sharon M.

AU - Herold, Betsy

AU - Mesquita, Pedro M M

AU - Richardson-Harman, Nicola

AU - Cunningham, Tina

AU - Schwartz, Jill L.

AU - Doncel, Gustavo F.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, antimicrobial activity of the cervicovaginal (CV) lavage (CVL), vaginal flora, and p24 antigen production from CV tissues after ex vivo human immunodeficiency virus (HIV) infection between follicular (FOL) and luteal (LUT) phases of the menstrual cycle. CV tissue biopsies, CV secretions, and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV-seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 and Escherichia coli by the CVL, vaginal pH or Nugent score, or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL phase versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials.

AB - The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, antimicrobial activity of the cervicovaginal (CV) lavage (CVL), vaginal flora, and p24 antigen production from CV tissues after ex vivo human immunodeficiency virus (HIV) infection between follicular (FOL) and luteal (LUT) phases of the menstrual cycle. CV tissue biopsies, CV secretions, and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV-seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 and Escherichia coli by the CVL, vaginal pH or Nugent score, or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL phase versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84971376574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971376574&partnerID=8YFLogxK

U2 - 10.1089/aid.2015.0264

DO - 10.1089/aid.2015.0264

M3 - Article

C2 - 26750085

AN - SCOPUS:84971376574

VL - 32

SP - 547

EP - 560

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 6

ER -